Vanda Pharmaceuticals Inc. — Investor Relations & Filings
Filings indexed
1,021
across all filing types
Latest filing
2026-02-11
Regulatory Filings
Country
US
United States of America
Listing
US
VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of innovative therapies. The company aims to address high unmet medical needs, with a particular focus on treatments for central nervous system disorders. Its portfolio includes both commercialized products and a pipeline of clinical-stage therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K Filing | 2026-02-11 | English | |
| SCHEDULE 13G/A Filing | 2026-01-21 | English | |
| SCHEDULE 13G/A Filing | 2026-01-09 | English | |
| 8-K Filing | 2026-01-08 | English | |
| 8-K | 2025-12-30 | English | |
| 8-K | 2025-12-04 | English |
Browse filings by year
19 years- 2026 19 filings
- 2025 52 filings
- 2024 64 filings
- 2023 60 filings
- 2022 45 filings
- 2021 52 filings
- 2020 64 filings
- 2019 57 filings
- 2018 57 filings
- 2017 45 filings
- 2016 53 filings
- 2015 69 filings
- 2014 59 filings
- 2013 61 filings
- 2012 49 filings
- 2011 40 filings
- 2010 73 filings
- 2009 85 filings
- 2008 17 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 29017840 | 8-K Filing | 2026-02-11 | English | ||
| 29017963 | SCHEDULE 13G/A Filing | 2026-01-21 | English | ||
| 29017760 | SCHEDULE 13G/A Filing | 2026-01-09 | English | ||
| 29017754 | 8-K Filing | 2026-01-08 | English | ||
|
2025
11 filings
| |||||
| 11923616 | 8-K | 2025-12-30 | English | ||
| 11923611 | 8-K | 2025-12-04 | English | ||
| 11923612 | 8-K | 2025-11-28 | English | ||
| 11923624 | 10-Q | 2025-10-30 | English | ||
| 11923618 | 8-K | 2025-10-29 | English | ||
| 11923619 | 8-K | 2025-10-01 | English | ||
| 11923635 | 4 | 2025-08-08 | English | ||
| 11923634 | 10-Q | 2025-07-31 | English | ||
| 11923628 | 8-K | 2025-07-31 | English | ||
| 11923636 | Major Shareholding Notification 2025 | 2025-07-01 | English | ||
| 11923637 | 4 | 2025-06-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Vanda Pharmaceuticals Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33390/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33390 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33390 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33390 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33390}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vanda Pharmaceuticals Inc. (id: 33390)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.